| ²é¿´: 2305 | »Ø¸´: 11 | |||||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||||
rhett82½ð³æ (СÓÐÃûÆø)
ÆÐÌá±¾ÎÞÊ÷,Ã÷¾µÒà·Ç̨,±¾À´ ...
|
[½»Á÷]
¡¾Ô´´¡¿×Ô¼º×ܽáµÄһЩ¶«Î÷£¬Ï£Íû¶Ô´ó¼ÒÓÐËù°ïÖú£¡
|
||||
|
¸üÒÂÊÒ Changing Room Ò»¸ü First Changing Room ÊÖÏûÊÒ Hands Disinfection Room ÆøÕ¢ÊÒ Airlock Room ½à¾ßÊÒ Cleaning Tools Room ÇåÏ´ÊÒ Cleaning Room Ä£¾ßÊÒ Dies Room ÄÚ°ü×°ÊÒ Immediate Package Room °²È«ÃÅ Emergency Door Íâ°üÇåÊÒ Outer Package Removing Room ´æÁϼä Storage Room of Raw Materials ·ÛËéÊÒ Pulverizing Room ±¸ÁÏÊÒ Materials Preparing Room Ó²½ºÊÒ Hard Capsules Filling Room Èí½ºÊÒ Soft Capsules Room ÖÆÁ£¸ÉÔïÊÒ Granulating and Drying Room ×Ü»ì¼ä Blending Room ÖмäÕ¾ Intermediate Station ѹƬÊÒ Tablets Room Compression Room °üÒÂÊÒ Coating Room Å佬¼ä Coating Mixture Preparing Room ÂÁËܰü×°¼ä Packing Room ´«µÝ´° Transferring Window Íâ°ü×°ÊÒ Outer Packing Room ÕôÁóË®ÊÒ Water Purifying Room ÖʼìÊÒ Quality Control Room ŨÅäÊÒ Concentrated Solution Room Ï¡ÅäÊÒ Diluted Solution Room BATCH PRODUCTION£ºÅúÁ¿Éú²ú£»·ÖÅúÉú²ú BATCH PRODUCTION RECORDS£ºÉú²úÅúºÅ¼Ç¼ POST-OR PRE- MARKET SURVEILLANCE£ºÏúÊÛǰ»òÏúÊÛºó¼à¶½ INFORMED CONSENT£ºÖªÇéͬÒ⣨»¼Õß¶ÔÖÎÁÆ»òÊÜÊÔÕß¶ÔÒ½ÁÆÊÔÑéÁ˽âºó±íʾͬÒâ½ÓÊÜÖÎ ÁÆ»òÊÔÑ飩 PRESCRIPTION DRUG£º´¦·½Ò© OTC DRUG£¨OVER¡ªTHE¡ªCOUNTER DRUG£©£º·Ç´¦·½Ò© U£®S£®PUBLIC HEALTH SERVICE£ºÃÀ¹úÎÀÉú¸£Àû²¿ Ò©Æ·ÖÆ±¸ preparation of drug products Õë¶Ô pertain to ÈËÓÃÉúÎïÖÆÆ· biological products for human use ²¹³ä supplement ´úÌæÌõÀý supersede the requlation ÌáÒéÃâ³ý proposed exemption Ò»°ãÏúÊÛºÍÏû·Ñ ordinarily marketed and consumed ÃÀµÂ£¬Óŵ㣬ЧÁ¦ virtue Áª°î×¢²á±í FR/federal register ÈËÓÃÎïÆ· human foods ÓÃÓÚ¼ø±ð£¬²â¶¨ shall be applied in determining Éú²ú£¬¼Ó¹¤£¬°ü×°£¬Öü´æ manufacture,process,pack,hold, Ö°ÔðºÍȨÁ¦ responsibility and authority Åú×¼ºÍ¾ÜÊÕ approve or reject/withhold ¸´²éÉú²ú¼Ç¼ review production records ¶ÔqcÀ´Ëµ¿ÉÒÔ»ñµÃµÄ shall be available to QC Êʵ±µÄ adequate Ч¼ÛºÍº¬Á¿ strength Ìṩ֤Ã÷Îļþ shall be documented ·ûºÏ conform to ÖÆ¶©ÍêÉÆ sound ÿװ»õÁ¿ each shipment ±äÖ浀 is subject to deterioration accommodation (³µ£¬´¬£¬·É»úµÈµÄ)Ô¤¶¨ÆÌλ ÅúºÅ batch Óк¦Î¢ÉúÎï objectionable microorganism ÁªºÏÅúºÅ the number of units ׼ȷÐÔ£¬ÁéÃôÐÔ£¬ÌØÒìÐÔ£¬Öظ´ÐÔ accuracy, sensitivity, specificity, and reproducibility ÌØÕ÷£¬ÊôÐÔ attribute ÅäÎé reconstitution Éè¼Æ project Ë³ÊÆÖÎÁÆÒ©Æ· homeopathic drug products ¿ÉÅäÎéÐÔ compatibility ±êÃ÷ purporting to Ó¦³ÉÎIJ¢×ñÑ shall be in writing and shall be followed. ¿É¼ì³öˮƽ detectable levels ͨ¹ý²Î¿¼ÎÄÏ×¾ßÌ廯 incorporated by reference ¸±×÷Óà adeverse/side effect ÀàÐÍ type »ì·Å mixups Ç©ÊÕ receipt ´¦Àí disposition ÕýѹϹýÂË be filtered under positive pressure ²ãÁ÷»ò·Ç²ãÁ÷ laminar or nonlaminar; ÎÞ¾ú»·¾³ aseptic conditions ÕÕÃ÷ lighting ͨ·ç¡¢¿ÕÆø¹ýÂË¡¢¿ÕÆø¼ÓÈÈÓëÀäÈ´ Ventilation, air filtration, air heating and cooling. ¿ÕÆøÊäËÍϵͳ Air-handling systems ¸½½ü½¨ÖþÎï immediate premises רÓÃë½í single-service towels ½øÁÏ Charge-in ±êʾÁ¿»ò¹æ¶¨Á¿ labeled or established amount ʵ¼Ê²úÁ¿ Actual yields ÀíÂÛ²úÁ¿ theoretical yields Éú²úÖÜÆÚ the production of a batch of a drug product Ò©Æ·µÄÒ»ÖÂÐÔºÍÍêÕûÐÔ uniformity and integrity of drug products ±À½âʱ¼ä Disintegration time ÈÜÒºµÄ³ÎÃ÷¶È¡¢ÈܽâÍêÈ«ÐÔ¼°pHÖµ Clarity, completeness, or pH of solutions Îȶ¨ÐÔÆÀ¹À variability estimates װж handling NIH£¨NATIONAL INSTITUTE OF HEALTH£©£º£¨ÃÀ¹ú£©È«¹úÎÀÉúÑо¿Ëù CLINICAL TRIAL£ºÁÙ´²ÊÔÑé ANIMAL TRIAL£º¶¯ÎïÊÔÑé ACCELERATED APPROVAL£º¼ÓËÙÅú×¼ FDA£¨FOOD AND DRUG ADMINISTRATION£©£º£¨ÃÀ¹ú£©Ê³Æ·Ò©Æ·¹ÜÀí¾Ö IND£¨INVESTIGATIONAL NEW DRUG£©£ºÁÙ´²Ñо¿ÉêÇ루ָÉ걨½×¶Î£¬Ïà¶Ô ÓÚNDA¶øÑÔ£©£»Ñо¿ÖеÄÐÂÒ©£¨Ö¸ÐÂÒ©¿ª·¢½×¶Î£¬Ïà¶ÔÓÚÐÂÒ©¶øÑÔ£¬¼´ÁÙ´²Ç°Ñо¿½áÊø£© NDA£¨NEW DRUG APPLICATION£©£ºÐÂÒ©ÉêÇë ANDA£¨ABBREVIATED NEW DRUG APPLICATION£©£º¼ò»¯ÐÂÒ©ÉêÇë EPËߣ¨EXPORT APPLICATION £©£º³ö¿ÚÒ©ÉêÇ루ÉêÇë³ö¿Ú²»±»Åú×¼ÔÚÃÀ¹ú ÏúÊÛµÄÒ©Æ·£© TREATMENT IND£ºÑо¿ÖеÄÐÂÒ©ÓÃÓÚÖÎÁÆ ABBREVIATED£¨NEW£©DRUG£º¼ò»¯ÉêÇëµÄÐÂÒ© DMF£¨DRUG MASTER FILE£©£ºÒ©ÎïÖ÷Îļþ£¨³ÖÓÐÕßΪ½÷É÷Æð¼û¶ø×¼±¸µÄ±£ ÃÜ×ÊÁÏ£¬¿ÉÒÔ°üÀ¨Ò»¸ö»ò¶à¸öÈËÓÃÒ©ÎïÔÚÖÆ±¸¡¢¼Ó¹¤¡¢ °ü×°ºÍÖü´æ¹ý³ÌÖÐËù¼°µÄÉ豸¡¢Éú²ú¹ý³Ì»òÎïÆ·¡£Ö»ÓÐÔÚDMF³ÖÓÐÕß»òÊÚȨ´ú±íÒÔÊÚȨÊéµÄÐÎʽÊÚȨ¸øFDA£¬FDAÔÚÉó²éIND¡¢NDA¡¢ANDAʱ²ÅÄܲο¼ÆäÄÚÈÝ£© HOLDER£ºDMF³ÖÓÐÕß CFR£¨CODE OF FEDERAL REGULATION£©£º£¨ÃÀ¹ú£©Áª°î·¨¹æ PANEL£º×¨¼ÒС×é BATCH PRODUCTION£ºÅúÁ¿Éú²ú£»·ÖÅúÉú²ú BATCH PRODUCTION RECORDS£ºÉú²úÅúºÅ¼Ç¼ POST-OR PRE- MARKET SURVEILLANCE£ºÏúÊÛǰ»òÏúÊÛºó¼à¶½ INFORMED CONSENT £ºÖªÇéͬÒ⣨»¼Õß¶ÔÖÎÁÆ»òÊÜÊÔÕß¶ÔÒ½ÁÆÊÔÑéÁ˽âºó±íʾͬÒâ½ÓÊÜÖÎÁÆ»òÊÔÑ飩 PRESCRIPTION DRUG£º´¦·½Ò© OTC DRUG£¨OVER¡ªTHE¡ªCOUNTER DRUG£©£º·Ç´¦·½Ò© U£®S£®PUBLIC HEALTH SERVICE£ºÃÀ¹úÎÀÉú¸£Àû²¿ NIH£¨NATIONAL INSTITUTE OF HEALTH£©£º£¨ÃÀ¹ú£©È«¹úÎÀÉúÑо¿Ëù CLINICAL TRIAL£ºÁÙ´²ÊÔÑé ANIMAL TRIAL£º¶¯ÎïÊÔÑé ACCELERATED APPROVAL£º¼ÓËÙÅú×¼ Acceptance Criteria ¨C ½ÓÊÕ±ê×¼ ½ÓÊÕ²âÊÔ½á¹ûµÄÊý×ÖÏÞ¶È¡¢·¶Î§»òÆäËüºÏÊʵÄÁ¿¶È±ê×¼¡£ Active Pharmaceutical Ingredient (API)(or Drug Substance) ¨C »îÐÔÒ©ÓÃ³É·Ö (ÔÁÏÒ©) Ö¼ÔÚÓÃÓÚÒ©Æ·ÖÆÔìÖеÄÈκÎÒ»ÖÖÎïÖÊ»òÎïÖʵĻìºÏÎ¶øÇÒÔÚÓÃÓÚÖÆÒ©Ê±£¬³ÉΪҩƷµÄÒ»ÖÖ»îÐԳɷ֡£´ËÖÖÎïÖÊÔÚ¼²²¡µÄÕï¶Ï£¬ÖÎÁÆ£¬Ö¢×´»º½â£¬´¦Àí»ò¼²²¡µÄÔ¤·ÀÖÐÓÐÒ©Àí»îÐÔ»òÆäËüÖ±½Ó×÷Ó㬻òÕßÄÜÓ°Ïì»úÌåµÄ¹¦Äܺͽṹ¡£ API Starting Material ¨C ÔÁÏÒ©µÄÆðʼÎïÁÏ ÓÃÔÚÔÁÏÒ©Éú²úÖеģ¬ÒÔÖ÷Òª½á¹¹µ¥Ôª±»²¢Èë¸ÃÔÁÏÒ©µÄÔÁÏ¡¢ÖмäÌå»òÔÁÏÒ©¡£ÔÁÏÒ© µÄÆðʼÎïÁÏ¿ÉÄÜÊÇÔÚÊг¡ÉÏÓÐÊÛ£¬Äܹ»¸ù¾ÝºÏͬ»òÉÌÒµÐÒé´ÓÒ»¸ö»ò¶à¸ö¹©Ó¦ÉÌ´¦¹ºµÃ£¬»òÕß×Ô¼ºÉú²ú¡£ÔÁÏÒ©µÄÆðʼÎïÁÏͨ³£ÓÐÌØ¶¨µÄ»¯Ñ§ÌØÐԺͽṹ¡£ Batch (or Lot) ¨C Åú ÓÉÒ»¸ö»òһϵÁй¤ÒÕ¹ý³ÌÉú²úµÄÒ»¶¨ÊýÁ¿µÄÎïÁÏ£¬Òò´ËÔڹ涨µÄÏÞ¶ÈÄÚÊǾùÒ»µÄ¡£ÔÚÁ¬ÐøÉú²úÖУ¬Ò»Åú¿ÉÄܶÔÓ¦ÓÚÓëÉú²úµÄÄ³Ò»ÌØ¶¨²¿·Ö¡£ÆäÅúÁ¿¿É¹æ¶¨ÎªÒ»¸ö¹Ì¶¨ÊýÁ¿£¬»òÔڹ̶¨Ê±¼ä¼ä¸ôÄÚÉú²úµÄÊýÁ¿¡£ Batch Number (or Lot Number) ¨C ÅúºÅ ÓÃÓÚ±êʶһÅúµÄÒ»¸öÊý×Ö¡¢×ÖĸºÍ/»ò·ûºÅµÄΨһ×éºÏ£¬´ÓÖпÉÈ·¶¨Éú²úºÍÏúÊÛµÄÀúÊ·¡£ Bioburden ¨C ÉúÎï¸ºÔØ ¿ÉÄÜ´æÔÚÓÚÔÁÏ¡¢ÔÁÏÒ©µÄÆðʼÎïÁÏ¡¢ÖмäÌå»òÔÁÏÒ©ÖеÄ΢ÉúÎïµÄˮƽºÍÖÖÀà(ÀýÈ磬Ö²¡µÄ»ò²»Ö²¡µÄ)¡£ÉúÎï¸ºÔØ²»Ó¦µ±µ±×÷ÎÛȾ£¬³ý·Çº¬Á¿³¬±ê£¬»òÕß²âµÃÖ²¡ÉúÎï¡£ Calibration ¨C УÑé Ö¤Ã÷ij¸öÒÇÆ÷»ò×°ÖÃÔÚÒ»Êʵ±µÄÁ¿³Ì·¶Î§ÄÚËù²âµÃµÄ½á¹ûÓëÒ»²ÎÕÕÎ»ò¿É×·Ëݵıê×¼Ïà±ÈÔڹ涨ÏÞ¶ÈÄÚ¡£ Computer System ¨C ¼ÆËã»úϵͳ Éè¼Æ°²×°ÓÃÓÚÖ´ÐÐijһÏî»òÒ»×鹦ÄܵÄÒ»×éÓ²¼þÔª¼þºÍ¹ØÁªµÄÈí¼þ¡£ Computerized System ¨C ¼ÆËã»ú»¯ÏµÍ³ Óë¼ÆËã»úϵͳÕûºÏµÄÒ»¸ö¹¤ÒÕ»ò²Ù×÷¡£ Contamination ¨C ÎÛȾ ÔÚÉú²ú¡¢È¡Ñù¡¢°ü×°»òÖØÐ°ü×°¡¢Öü´æ»òÔËÊä¹ý³ÌÖУ¬¾ß»¯Ñ§»ò΢ÉúÎïÐÔÖʵÄÔÓÖÊ»òÍâÀ´ÎïÖʽøÈë»òմȾÔÁÏ¡¢ÖмäÌå»òÔÁÏÒ©¡£ Contract Manufacturer ¨C ÐÒéÖÆÔìÉÌ ´ú±íÔÖÆÔìÉ̽øÐв¿·ÖÖÆÔìµÄÖÆÔìÉÌ¡£ Critical ¨C ¾ö¶¨Ð﵀ ÓÃÀ´ÃèÊöΪÁËÈ·±£ÔÁÏÒ©·ûºÏ¹æ¸ñ±ê×¼£¬±ØÐë¿ØÖÆÔÚÔ¤¶¨·¶Î§ÄڵŤÒÕ²½Öè¡¢¹¤ÒÕÌõ¼þ¡¢²âÊÔÒªÇó»òÆäËüÓйزÎÊý»òÏîÄ¿¡£ Cross-Contamination ¨C ½»²æÎÛȾ Ò»ÖÖÎïÁÏ»ò²úÆ·¶ÔÁíÒ»ÖÖÎïÁÏ»ò²úÆ·µÄÎÛȾ¡£ Deviation ¨C Æ«²î ¶ÔÅú×¼µÄÖ¸Áî»ò¹æ¶¨µÄ±ê×¼µÄÆ«Àë¡£ Drug (Medicinal) Product ¨C Ò©Æ· ¾×îºó°ü×°×¼±¸ÏúÊÛµÄÖÆ¼Á(²Î¼ûQ1A)¡£ Drug Substance ¨C Ò©Îï ¼ûÔÁÏÒ© Expiry Date (or Expiration Date) ¨C ÓÐЧÆÚ ÔÁÏÒ©ÈÝÆ÷/±êÇ©ÉÏ×¢Ã÷µÄÈÕÆÚ£¬Ôڴ˹涨ʱ¼äÄÚ£¬¸ÃÔÁÏÒ©Ôڹ涨Ìõ¼þÏÂÖü´æÊ±£¬ÈÔ·ûºÏ¹æ¸ñ±ê×¼£¬³¬¹ýÕâÒ»ÆÚÏÞÔò²»Ó¦µ±Ê¹ÓᣠImpurity ¨C ÔÓÖÊ ´æÔÚÓÚÖмäÌå»òÔÁÏÒ©ÖУ¬Èκβ»Ï£ÍûµÃµ½µÄ³É·Ö¡£ Impurity Profile ¨C ÔÓÖʸſö ¶Ô´æÔÚÓÚÒ»ÖÖÔÁÏÒ©ÖеÄÒÑÖªºÍδ֪ÔÓÖʵÄÃèÊö¡£ In-Process Control (or Process Control) ¨C ÖÐ¼ä¿ØÖÆ Éú²ú¹ý³ÌÖÐΪ¼à²â£¬ÔÚ±ØÒªÊ±µ÷½Ú¹¤ÒÕºÍ/»ò±£Ö¤ÖмäÌå»òÔÁÏÒ©·ûºÏÆä¹æ¸ñ¶ø½øÐеļì²é¡£ Intermediate ¨C ÖмäÌå ÔÁÏÒ©¹¤ÒÕ²½ÖèÖвúÉúµÄ¡¢±ØÐë¾¹ý½øÒ»²½·Ö×ӱ仯»ò¾«ÖƲÅÄܳÉΪÔÁÏÒ©µÄÒ»ÖÖÎïÁÏ¡£ÖмäÌå¿ÉÒÔ·ÖÀë»ò²»·ÖÀë¡£(×¢£º±¾Ö¸ÄÏֻɿ¼°¸Ã¹«Ë¾¶¨ÒåΪÔÁÏÒ©Éú²úÆðʼµãÒÔºóÉú²úµÄÖмäÌå¡£) Lot ¨C Åú ¼ûÅú(Batch)¡£ Lot Number ¨C ÅúºÅ ¼ûÅúºÅ(Batch Number) Manufacture ¨C ÖÆÔì ÎïÁϵĽÓÊÕ¡¢ÔÁÏÒ©µÄÉú²ú¡¢°ü×°¡¢ÖØÐ°ü×°¡¢ÌùÇ©¡¢ÖØÐÂÌùÇ©¡¢ÖÊÁ¿¿ØÖÆ¡¢·ÅÐС¢Öü´æºÍ·Ö·¢ÒÔ¼°Ïà¹Ø¿ØÖƵÄËùÓвÙ×÷¡£ Material ¨C ÎïÁÏ ÔÁÏ(ÆðʼÎïÁÏ£¬ÊÔ¼Á£¬ÈܼÁ)£¬¹¤ÒÕ¸¨ÖúÓÃÆ·£¬ÖмäÌ壬ÔÁÏÒ©£¬ ºÍ°ü×°¼°ÌùÇ©²ÄÁϵÄͳ³Æ¡£ Mother Liquor ¨C ĸҺ ½á¾§»ò·ÖÀëºóʣϵIJÐÁôÒº¡£Ä¸Òº¿ÉÄܺ¬ÓÐδ·´Ó¦µÄÎïÁÏ¡¢ÖмäÌå¡¢²»Í¬¼¶±ðµÄÔÁÏÒ©ºÍ/»òÔÓÖÊ¡£Ëü¿ÉÓÃÓÚ½øÒ»²½¼Ó¹¤¡£ Packaging Material ¨C °ü×°²ÄÁÏ ÔÚ´¢Ô˹ý³ÌÖб£»¤ÖмäÌå»òÔÁÏÒ©µÄÈκÎÎïÁÏ¡£ Procedure ¨C ³ÌÐò ¶ÔÒª½øÐеIJÙ×÷¡¢Òª²ÉÈ¡µÄÔ¤·À´ëÊ©ÒÔ¼°ÓëÔÁÏÒ©»òÖмäÌåÉú²úÖ±½Ó»ò¼ä½ÓÏà¹ØµÄ·½·¨µÄÃèÊöÎļþ¡£ Process Aids ¨C ¹¤ÒÕ¸¨ÁÏ ³ýÈܼÁÍ⣬ÔÚÔÁÏÒ©»òÖмäÌåÉú²úÖÐÆð¸¨Öú×÷Óᢱ¾Éí²»²ÎÓ뻯ѧ»òÉúÎïѧ·´Ó¦µÄÎïÁÏ(ÀýÈ磬ÖúÂ˼Á¡¢»îÐÔÌ¿)¡£ Process Control ¨C ¹¤ÒÕ¿ØÖÆ ¼ûÖÐ¼ä¿ØÖÆ Production ¨C Éú²ú ÔÚÔÁÏÒ©ÖÆ±¸¹ý³ÌÖУ¬´Ó½ÓÊÕÔÁÏ£¬µ½¹¤ÒÕ¼Ó¹¤ºÍÔÁÏÒ©°ü×°ËùÉæ¼°µÄËùÓвÙ×÷¡£ Qualification ¨C È·ÈÏ Ö¤Ã÷É豸»ò¸¨Öúϵͳ£¬°²×°ÕýÈ·¡¢¹¤×÷Õý³£¡¢È·Êµ²úÉúÔ¤ÆÚµÄ½á¹û£¬²¢ÒÔÎļþ×ôÖ¤µÄÐÐΪ¡£È·ÈÏÊÇÑéÖ¤µÄÒ»²¿·Ö£¬µ«µ¥¶ÀµÄÈ·Èϲ½Öè²»¹¹³É¹¤ÒÕÑéÖ¤¡£ Quality Assurance (QA) ¨C ÖÊÁ¿±£Ö¤ ÒÔÈ·±£ËùÓÐÔÁÏÒ©´ïµ½ÆäÓ¦ÓÃËùÒªÇóµÄÖÊÁ¿£¬²¢Î¬³ÖÖÊÁ¿ÌåϵΪĿµÄµÄÈ«²¿×éÖ¯°²ÅŵÄ×ܺ͡£ Quality Control ¨C ÖÊÁ¿¿ØÖÆ ÊÇ·ñ·ûºÏÖÊÁ¿¹æ¸ñµÄ¼ì²é»ò²âÊÔ¡£ Quality Unit(s) ¨C ÖÊÁ¿²¿ÃÅ ¶ÀÁ¢ÓÚÉú²ú²¿ÃŵÄÂÄÐÐÖÊÁ¿±£Ö¤ºÍÖÊÁ¿¿ØÖÆÖ°ÔðµÄ×éÖ¯»ú¹¹¡£°´ÕÕ×éÖ¯»ú¹¹µÄ´óСºÍ½á¹¹£¬¿ÉÒÔÊǵ¥¶ÀµÄQA ºÍQC²¿ÃÅ£¬»ò¸öÈË£¬»òС×é¡£ Quarantine ¨C ´ýÑé ÔÚʵÎïÉÏ»òÒÔÆäËüÓÐЧ·½Ê½½«ÎïÁϸôÀ룬µÈ´ý¶ÔÆäËæºóµÄÅú×¼»ò¾ÜÊÕ×ö³ö¾ö¶¨µÄ״̬¡£ Raw Material ¨C ÔÁÏ ÓÃÀ´±íʾÖмäÌå»òÔÁÏÒ©µÄÉú²úÖÐÒªÓÃµÄÆðʼÎïÁÏ¡¢ÊÔ¼ÁºÍÈܼÁµÄͨÓÃרҵÃû´Ê¡£ Reference Standard, Primary ¨C »ù×¼²Î¿¼±ê׼Ʒ ¾¹ã·º·ÖÎö²âÊÔ±íÃ÷¾ßÓпÉÐŵĸߴ¿¶ÈµÄÎïÖÊ¡£ÕâÀà±ê׼Ʒ¿ÉÒÔ£º1)À´Ô´ÓÚ·¨¶¨µÄ»ú¹¹£¬2)¶ÀÁ¢ºÏ³É£¬3)À´×ÔÓڸߴ¿¶ÈµÄÏÖÓÐÉú²úÎïÁÏ£¬»ò4)ÓýøÒ»²½¾«ÖÆÏÖÓÐÉú²úÎïÁϵķ½·¨À´ÖƱ¸¡£ Reference Standard, Secondary ¨C ¶þ¼¶²Î¿¼±ê׼Ʒ Óë»ù×¼²Î¿¼±ê׼Ʒ±È½ÏÏÔʾ¾ßÓй涨µÄÖÊÁ¿ºÍ´¿¶È£¬²¢ÓÃ×÷ÈÕ³£ÊµÑéÊÒ·ÖÎöµÄ²Î¿¼±ê׼Ʒ¡£ Reprocessing ¨C ·µ¹¤ ½«²»·ûºÏ±ê×¼»ò¹æ¸ñµÄÒ»¸öÖмäÌå»òÔÁÏÒ©·µ»Ø¹¤ÒÕ¹ý³Ì£¬Öظ´¹æ¶¨µÄÉú²ú¹¤ÒÕÖеÄijһ½á¾§²½Öè»òÆäËüºÏÊʵĻ¯Ñ§»òÎïÀí´¦Àí²½Öè (Èç ÕôÁ󣬹ýÂË£¬²ãÎö£¬Ä¥·Û)£¬ÕâÖÖ×ö·¨Í¨³£ÊÇ¿ÉÒÔ½ÓÊܵġ£ÔÚÖÐ¼ä¿ØÖÆµÄ²âÊÔ±íÃ÷Ò»¹¤ÒÕ²½ÖèûÓÐÍê³É£¬´Ó¶ø¼ÌÐø¸Ã²½Ö裬ÊÇÕý³£¹¤ÒÕµÄÒ»²¿·Ö£¬¶ø²»ÊÇ·µ¹¤¡£ Retest Date ¨C ¸´ÑéÈÕÆÚ ÎïÁÏÓ¦µ±ÖØÐ¼ìÑéÒÔÈ·±£ÆäÈÔ¿ÉʹÓõÄÈÕÆÚ¡£ Reworking ¨C ÖØÐ¼ӹ¤ ½«²»·ûºÏ¹æ¸ñ±ê×¼µÄÖмäÌå»òÔÁÏÒ©Óò»Í¬Óڹ涨Éú²ú¹¤ÒÕµÄÒ»¸ö»ò¼¸¸ö²½Öè½øÐд¦Àí£¬ÒԵõ½ÖÊÁ¿¿É½ÓÊܵÄÖмäÌå»òÔÁÏÒ©(È磺Óò»Í¬ÈܼÁµÄÔٽᾧ)¡£ Signature (Signed) ¨C Ç©Ãû ×ö¹ýÄ³Ò»ÌØ¶¨Ðж¯»òÉóºËµÄ¸öÈ˵ÄÒ»ÖּǼ¡£´ËÀà¼Ç¼¿ÉÒÔÊÇÊ××ÖĸËõд¡¢ÊÖдȫÃû¡¢¸öÈËÓ¡Õ»ò¾Ö¤ÊµµÄ¿É¿¿µÄµç×ÓÇ©Ãû¡£ Solvent ¨C ÈܼÁ ÖмäÌå»òÔÁÏÒ©ÖÐÓÃ×÷ÖÆ±¸ÈÜÒº»òÐü¸¡ÒºµÄÔØÌåµÄÎÞ»ú»òÓлúÒºÌå¡£ Specification ¨C ¹æ¸ñ һϵÁеIJâÊÔÏîÄ¿¡¢ÓйصķÖÎö³ÌÐòºÍÊʵ±µÄÈϿɱê×¼£¬´Ë±ê×¼¿ÉÒÔÊÇÊýÖµÏÞ¶È¡¢·¶Î§»òËùÊö²âÊÔÏîÄ¿µÄÆäËü±ê×¼¡£Ëü¹æ¶¨Ò»Ì×±ê×¼£¬ÎïÁÏÓ¦µ±·ûºÏ¸Ã±ê×¼£¬²Å±»ÈÏΪ¿ÉÒÔÓÃ×÷ÆäÔ¤ÆÚµÄÓÃ;¡£ ¡°·ûºÏ¹æ¸ñ¡±±íʾÎïÁϰ´ËùÁеķÖÎö³ÌÐò²âÊÔʱ£¬»á·ûºÏËùÁеĽÓÊܱê×¼¡£ Validation ¨C ÑéÖ¤ ÎªÄ³Ò»ÌØ¶¨µÄ¹¤ÒÕ¡¢·½·¨»òϵͳÄܹ»³ÖÐøµØ²úÉú·ûºÏ¼È¶¨½ÓÊܱê×¼µÄ½á¹ûÌṩ³ä·Ö±£Ö¤µÄÎļþ³ÌÐò¡£ Validation Protocol ¨C ÑéÖ¤·½°¸ ˵Ã÷ÈçºÎ½øÐÐÑéÖ¤ºÍ¹æ¶¨½ÓÊܱê×¼µÄÊéÃæ¼Æ»®¡£ÀýÈ磬Éú²ú¹¤ÒÕÑéÖ¤·½°¸È·¶¨¹¤ÒÕÉ豸¡¢¹Ø¼üÐÔ¹¤ÒÕ²ÎÊý/²Ù×÷·¶Î§¡¢²úÆ·ÌØÐÔ¡¢È¡Ñù¡¢ÊÕ¼¯µÄ²âÊÔÊý¾Ý¡¢ÑéÖ¤µÄ´ÎÊý£¬ÒÔ¼°¿É½ÓÊܵIJâÊÔ½á¹û¡£ Yield, Expected ¨C Ô¤ÆÚ²úÁ¿ ÔÚÒÔǰʵÑéÊÒ¡¢ÖÐÊÔ¹æÄ£»òÉú²úÊý¾ÝµÄ»ù´¡ÉÏ£¬Ô¤¼ÆÈκÎÊʵ±µÄÉú²ú½×¶ÎµÄÎïÁϵÄÁ¿»òÀíÂÛ²úÁ¿µÄ°Ù·Ö±È¡£ Yield, Theoretical ¨C ÀíÂÛ²úÁ¿ ¸ù¾ÝͶÁÏÁ¿£¬²»¼ÆÈκÎʵ¼ÊÉú²úÖеÄËðʧ»ò¹ýʧ£¬¼ÆËãÈκÎÊʵ±µÄÉú²ú½×¶ÎÉú²úµÄÁ¿¡£ [ Last edited by laizuliang on 2007-9-21 at 07:53 ] |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
ÖÆÒ© | ÖÊÁ¿ÏµÍ³ |
» ²ÂÄãϲ»¶
293Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
290Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
285»¯¹¤Ñ§Ë¶Çóµ÷¼Á£¨081700£©
ÒѾÓÐ8È˻ظ´
211±¾£¬11408Ò»Ö¾Ô¸ÖпÆÔº277·Ö£¬ÔøÔÚÖпÆÔº×Ô¶¯»¯Ëùʵϰ
ÒѾÓÐ5È˻ظ´
²ÄÁÏÓ뻯¹¤304ÇóBÇøµ÷¼Á
ÒѾÓÐ8È˻ظ´
ÓÐûÓдóÀз¢Ð¡ÂÛÎÄÄÜ´øÎÒ¸ö¶þ×÷
ÒѾÓÐ4È˻ظ´
¿¼Ñе÷¼Á
ÒѾÓÐ5È˻ظ´
267Ò»Ö¾Ô¸ÄϾ©¹¤Òµ´óѧ0817»¯¹¤Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
293Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
302Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

0.5
![]() |
2Â¥2006-05-10 17:57:02
3Â¥2006-05-10 18:09:10
1
|
4Â¥2006-05-10 20:34:49
bluesun
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 691.6
- Ìû×Ó: 285
- ÔÚÏß: 19.2Сʱ
- ³æºÅ: 133026
- ×¢²á: 2005-12-13
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É
5Â¥2006-05-10 23:16:54
charlie_321
ÖÁ×ðľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 12589.9
- Ìû×Ó: 488
- ÔÚÏß: 111.4Сʱ
- ³æºÅ: 187916
- ×¢²á: 2006-02-17
- ÐÔ±ð: GG
- רҵ: »ù´¡ÎïÀíѧ
6Â¥2007-03-09 12:32:34
0.25
|
7Â¥2007-03-09 12:54:13
|
8Â¥2007-03-09 16:21:30
9Â¥2007-03-10 21:33:51
yqfeng2001
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 2699.5
- É¢½ð: 5
- Ìû×Ó: 765
- ÔÚÏß: 545.9Сʱ
- ³æºÅ: 98183
- ×¢²á: 2005-11-09
- ÐÔ±ð: GG
- רҵ: Ó¦Óø߷Ö×Ó»¯Ñ§ÓëÎïÀí
10Â¥2007-03-11 10:41:19













»Ø¸´´ËÂ¥



